Home
Medical Links
Search Our Site
Medical Articles
Treatments
Message Boards
Online Store
Getting Started
Contact Us
Our Newsletter
Patient Sign-In
Evaluating Cardiac Risk - Treatment & Cardiac Risk Health Evaluation

Evaluating Cardiac Risk - Article Index


Treatment & Cardiac Risk Health Evaluation

Lifestyle Change:

Early on, lifestyle modification is often effective in controlling insulin resistance syndrome. This involves achieving ideal body weight and doing aerobic exercise 5 or more times per week. Hormonal correct diet. which should be low glycemic carbohydrate with moderate amounts of protein and a increase in dietary fiber.

Nutraceuticals:

  • Elemental magnesium glycinate 400mg a day
  • Vitamin E (tocophenol succinate not acetate), 1000mg a day max
  • Zinc Citrate, 30 to 60 mg
  • Taurine: 1gm twice a day
  • Chromium up to 1000mcg
  • Vanadium 25mg for about two to three months. Then down to 71/2 mg three times a day, then I'll go down further, then I take them off completely once they are better
  • L-glutamine 5 to 10 grams a day
  • L-carnitine 1000mg or more a day
  • Omega 3 fatty acids
  • Alpha Lipoic Acid 400mg a day

  • Gymnema Sylvestre

    • Pharmaceuticals:

    Treatment with Glucophage, Avandia, or Actos) is very effective. Later, as functional hypoglycemia appears, addition of a sulfonlyurea or Repaglinide may be useful but should be avoided if possible. The early treatment of choice is Metformin, an oral drug used in the treatment of type 2 diabetes. The dose is 500 or 850mg, three times per day with meals.. By lowering insulin resistance and insulin, this will help to do the following: Lower triglycerides, Elevate HDL cholesterol; Treat Type 2 diabetes (if present); Prevent the eventual appearance of Type 2 diabetes Lower blood pressure; Lower PAI-Fx(;plasminogen activator inhibitor activity causes increased risk of clotting) Lower uric acid; Lower body weight. Because Metformin does not lower blood glucose in normal subjects (non-diabetics), it can be given safely to people who are not diabetic.

    Abstracts:
    Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.
    Circulation 1997 Oct 21;96(8):2520-5


    CARDIAC HEALTH RISK EVALUATION
    Parameter
    Ideal Values
    Highest Risk
    HDL
    >65
    <35
    LDL
    <100
    >140
    HbA1c
    <5%
    >8%
    Fasting Insulin
    <10uU/ml
    >15uU/ml
    Triglyceride/HDL
    <2
    >4
    Total Cholesterol/HDL
    2
    >4
    Serum Ferritin
    >40 ng/ml <100 ng/ml
    >220 ng/ml
    Homocysteine
    <7
    >11
    Fibrinogen
    <300
    >350
    Lp(a)
    <15
    >25
    Body Fat % Male
    <16%
    >35%
    Body Fat % Female
    <22%
    >33%

    Fasting Insulin Levels PREVIOUS PAGE
    Evaluating Cardiac Risk - Article Index ARTICLE INDEX

    BACK TO TOP OF PAGE


    Disclaimer: The information contained on this website has not been evaluated by the FDA. This information is not intended to treat, diagnose, cure or prevent any disease. All material provided in the Dr. Brizel's web site is provided for educational purposes only. Always seek the advice of your physician or other qualified health care provider with any questions you have regarding a medical condition, and before undertaking any diet, exercise or other health program.

    ©2002, All Rights Reserved, Center For Clinical Age Management, Inc.